2019 annual financial data
TScan Therapeutics 2019 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -14.21M USD and net income was -13.66M USD.
Operating cash flow was -12.52M USD.
Get free TScan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14.21M USD
- Net income
- -13.66M USD
- Operating cash flow
- -12.52M USD